Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Myron S. Cohen, Peter B. Gilbert et al.|New England Journal of Medicine|2021Cited by 557
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trialHoosen Coovadia, Yvonne Maldonado, Wafaie Fawzi et al.|The Lancet|2011Cited by 142
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B. Gilbert, Lynn Morris, Yunda Huang et al.|Nature Medicine|2022Cited by 132
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy TrialsPeter B. Gilbert, Lawrence Corey, Michal Juraska et al.|Statistical Communications in Infectious Diseases|2017Cited by 96
PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)Roy M. Gulick, Kenneth H. Mayer, Timothy Wilkin et al.|The Journal of Infectious Diseases|2016Cited by 47